Robert de JongAssociate Director Antibody Research & Technology at Genmab
Profile
Dr. Rob de Jong has worked in different roles at Genmab since 2007, spanning a.o. molecular biology, CMC-supportive research, and protein engineering and is an inventor of Genmab’s HexaBody® and HexElect® technologies. He currently leads Genmab’s Antibody Format Development efforts, aimed at translating biomolecular and structural insights into novel therapeutic antibody platform technologies.
Robert de Jong's Network
Agenda Sessions
Therapeutic IgG Antibody Combinations Acting as Bio-Logic AND Gates
, 2:00pmView Session